CLINICAL_TRIALS
trial_result
· 2010-07-20
Clinical Trial Update: Clinical Trial of Sodium Phenylbutyrate in Children With Spinal Muscular Atrophy Type I [Phase 1, Phase 2]
Summary
A Phase 1/2 trial of sodium phenylbutyrate in children with spinal muscular atrophy Type I was terminated, with results posted in 2010.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Westat | Conditions: Spinal Muscular Atrophy Type I | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2010-07-20